Vancomycin
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Antibiotics & Anti-Infectives treatment.
🧴 Clinical Application
Administered strictly by a qualified healthcare professional by slow intravenous infusion diluted in at least 100-200 mL of compatible fluid over a minimum of 60 minutes (or rate not exceeding 10 mg/min) to prevent infusion-related reactions. Therapeutic drug monitoring (trough levels) is standard practice.
⚠️ Side Effects
Common: Infusion site pain, mild nausea. Rare/Severe: "Red Man Syndrome" (histamine-mediated flushing, erythematous rash on face/neck/torso, and hypotension caused by rapid IV infusion), nephrotoxicity (acute kidney injury), ototoxicity (hearing loss), neutropenia, and DRESS syndrome.
🛡️ Safety Warnings
Black box caution for nephrotoxicity and ototoxicity, especially when combined with aminoglycosides, loop diuretics, or piperacillin-tazobactam. Mandatory slow IV infusion rate (minimum 60 minutes) to avoid Red Man Syndrome. Monitor serum trough levels and kidney function routinely.
Jan Aushadhi Products containing Vancomycin
Found 3 generic formulation(s) containing this active ingredient.
Vancomycin Hydrochloride for Intravenous Infusion 500 mg
Vancomycin Hydrochloride is a tricyclic glycopeptide bactericidal antibiotic. It acts by inhibiting bacterial cell wall synthesis through binding with high affinity to the D-alanyl-D-alanine terminus of cell wall peptidoglycan precursors. Indicated intravenously for severe infections caused by methicillin-resistant Staphylococcus aureus (MRSA), enterococcal infections, endocarditis, and surgical prophylaxis in high-risk patients. When given orally (capsules), it is not absorbed systemically and acts locally to treat Clostridioides difficile-associated diarrhea (pseudomembranous colitis) and staphylococcal enterocolitis.
Vancomycin Hydrochloride for Intravenous Infusion 1000 mg
Vancomycin Hydrochloride is a tricyclic glycopeptide bactericidal antibiotic. It acts by inhibiting bacterial cell wall synthesis through binding with high affinity to the D-alanyl-D-alanine terminus of cell wall peptidoglycan precursors. Indicated intravenously for severe infections caused by methicillin-resistant Staphylococcus aureus (MRSA), enterococcal infections, endocarditis, and surgical prophylaxis in high-risk patients. When given orally (capsules), it is not absorbed systemically and acts locally to treat Clostridioides difficile-associated diarrhea (pseudomembranous colitis) and staphylococcal enterocolitis.
Vancomycin Hydrochloride Capsules 250mg
Vancomycin Hydrochloride is a tricyclic glycopeptide bactericidal antibiotic. It acts by inhibiting bacterial cell wall synthesis through binding with high affinity to the D-alanyl-D-alanine terminus of cell wall peptidoglycan precursors. Indicated intravenously for severe infections caused by methicillin-resistant Staphylococcus aureus (MRSA), enterococcal infections, endocarditis, and surgical prophylaxis in high-risk patients. When given orally (capsules), it is not absorbed systemically and acts locally to treat Clostridioides difficile-associated diarrhea (pseudomembranous colitis) and staphylococcal enterocolitis.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Vancomycin.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Vancomycin Hydrochloride for Intravenous Infusion 500 mg | Vial & Wfi | ₹135.00 | Vancoray, Vanking, Celovan | ₹189.11 | 29% Save |
| Vancomycin Hydrochloride for Intravenous Infusion 1000 mg | Vial | Under Process | N/A | N/A | N/A |
| Vancomycin Hydrochloride Capsules 250mg | 10's | Under Process | N/A | N/A | N/A |
Frequently Asked Questions (FAQ)
Get answers to common queries about Vancomycin generics.